/Companies

Acousia

Tübingen, DE · 6 known investors

Find your way into Acousia

Sign up to find every way you can get introduced to Acousia

  • Your email: who you already know at Acousia, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Acousia team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Acousia Therapeutics develops small-molecule drug candidates with a dual mode of action for treating acute and chronic sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear to preserve and enhance natural hearing. The biotech company focuses on drug therapies as a first-line or complementary option to hearing aids and cochlear implants.

Founders & leadership

HLHubert Löwenheim
Hubert LöwenheimFounder / Board Member

Investors · 6

Also in the syndicate · 1

Bregua Corporation

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Acousia do?
Acousia Therapeutics develops small-molecule drug candidates with a dual mode of action for treating acute and chronic sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear to preserve and enhance natural hearing. The biotech company focuses on drug therapies as a first-line or complementary option to hearing aids and cochlear implants.
Who founded Acousia?
Acousia was founded by Hubert Löwenheim.
Who are Acousia's investors?
Acousia's investors include Boehringer Ingelheim Venture Fund, KfW, Creathor Ventures, LBBW Venture Capital GmbH, Esperante Ventures.
Where is Acousia headquartered?
Acousia is headquartered in Tübingen, DE.